Noguera-Morel L., Hernández-Martin A., Torrelo A. Childhood rosacea and related disorders // Clin. Exp. Dermatol. 2021. Vol. 46. N. 3. P. 430–437. DOI: https://doi.org/10.1111/ced.14419. Epub 2020 Nov 20. PMID: 33217048.
Ohata C., Saruban H., Ikegami R. Granulomatous rosacea affecting the lacrimal and salivary glands // Arch. Dermatol. 2004. Vol. 140. N. 2. P. 240–242. DOI: https://doi.org/10.1001/archderm.140.2.240-b. PMID: 14967807.
O’Leary P., Kierland R.R. Pyoderma faciale // Arch. Dermatol. 1940. Vol. 41. N. 3. P. 451. DOI: https://doi.org/10.1001/archderm.1940.01490090003001.
Patterson C., Wilkinson J., Lewis F. Rosacea fulminans confined to the nose // J. Eur. Acad. Dermatol. Venereol. 2009. Vol. 23. N. 9. P. 1101–1102. DOI: https://doi.org/10.1111/j.1468–3083.2009.03098.x.
Plewig G., Jansen T. Rosacea disorders of epidermal appendages and related disorders // Dermatology in General Medicine. 5th ed. / Eds T.B. Fitzpatrick, I.M. Freedberg, A.Z. Eisen et al. New York, NY: McGraw-Hill, 1999. P. 785–792.
Plewig G., Jansen T., Kligman A.M. Pyoderma faciale. A review and report of 20 additional cases: is it rosacea? // Arch. Dermatol. 1992. Vol. 128. P. 1611–1617. DOI: https://doi.org/10.1001/archderm.1992.04530010049007.
Plewig G., Nikolowski J., Wolff H.H. Action of isotretinoin in acne rosacea and gram-negative folliculitis // J. Am. Acad. Dermatol. 1982. Vol. 6. P. 766–785. DOI: https://doi.org/10.1016/S0190-9622(82)70067-2.
Pogorzelska-Dyrbuś J., Sosnowski M., Szepietowski J.C. Rosacea fulminans with rhinophyma and severe eye complications in a young woman treated with isotretinoin // Postepy Dermatol. Alergol. 2021. Vol. 38. N. 5. P. 903–905. DOI: https://doi.org/10.5114/ada.2020.94743. Epub 2020 Apr 25. PMID: 34849142; PMCID: PMC8610035.
Rallis E., Korfitis C. Isotretinoin for the treatment of granulomatous rosacea: case report and review of the literature // J. Cutan. Med. Surg. 2012. Vol. 16. N. 6. P. 438–441. DOI: https://doi.org/10.1177/120347541201600615. PMID: 23149202.
Ranu H., Lee J., Hee T.H. Therapeutic hotline: successful treatment of Morbihan’s disease with oral prednisolone and doxycycline // Dermatol. Ther. 2010. Vol. 23. N. 6. P. 682–685. DOI: https://doi.org/10.1111/j.1529-8019.2010.01373.x. PMID: 21054712.
Razeghi S., Halvorson C.R., Gaspari A.A., Cross R.K. Successful treatment of localized pyoderma faciale in a patient with Crohn’s disease // Gastroenterol. Hepatol. (N.Y.). 2013. Vol. 9. N. 8. P. 541–543. PMID: 24719607; PMCID: PMC3981002.
Redd T.K., Seitzman G.D. Ocular rosacea // Curr. Opin. Ophthalmol. 2020. Vol. 31. N. 6. P. 503–507. DOI: https://doi.org/10.1097/ICU.0000000000000706. PMID: 33009083.
Saal R.C., Borda L.J., Hoffman M.L. et al. Treatment of granulomatous rosacea with adalimumab // JAAD Case Rep. 2023. Vol. 40. P. 89–91. DOI: https://doi.org/10.1016/j.jdcr.2023.08.017. PMID: 37771357; PMCID: PMC10523424.
Saki N., Amani M., Nezhad N.Z. et al. Efficacy and safety of topical brimonidine in dermatology: a review article // Dermatol. Ther. 2022. Vol. 35. N. 11. Article ID e15819. DOI: https://doi.org/10.1111/dth.15819. Epub 2022 Oct 3. PMID: 36097378.
Sánchez J.L., Berlingeri-Ramos A.C., Dueño D.V. Granulomatous rosacea // Am. J. Dermatopathol. 2008. Vol. 30. N. 1. P. 6–9. DOI: https://doi.org/10.1097/DAD.0b013e31815bc191. PMID: 18212536.
Sanz-Motilva V., Martorell Calatayud A., Rivera R., Vanaclocha-Sebastián F. Rosácea fulminans inducida por corticoides tópicos. Casos clinicos [Rosacea fulminans: report of two cases] // Rev. Med. Chil. 2012. Vol. 140. N. 5. P. 637–639. DOI: https://doi.org/10.4067/S0034-98872012000500013. PMID: 23096671. (In Spanish).
Schaller M., Almeida L.M.C., Bewley A. et al. Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel // Br. J. Dermatol. 2020. Vol. 182. N. 5. P. 1269–1276. DOI: https://doi.org/10.1111/bjd.18420. Epub 2019 Oct 16. PMID: 31392722; PMCID: PMC7317217.
Schaller M., Gonser L., Belge K. et al. Dual anti-inflammatory and anti-parasitic action of topical ivermectin 1% in papulopustular rosacea // J. Eur. Acad. Dermatol. Venereol. 2017. Vol. 31. N. 11. P. 1907–1911. DOI: https://doi.org/10.1111/jdv.14437. Epub 2017 Aug 29. PMID: 28653460.
Schewach-Millet M., Shpiro D., Trau H. Granulomatous rosacea // J. Am. Acad. Dermatol. 1988. Vol. 18. N. 6. P. 1362–1363. DOI: https://doi.org/10.1016/s0190-9622(88)80118-x. PMID: 2968381.
Schimpf A. Blepharitis et pareitis granulomatosa // Derm. Wschr. 1960. Vol. 141. P. 446.
Schimpf A. Dermatitis frontalis granulomatosa // Derm. Wschr. 1956. Vol. 133. P. 120.
Schimpf A. Dermatitis frontalis granulomatosa // Derm. Wschr. 1958. Vol. 138. P. 829–830.
Schimpf A. Dermatitis granulomatosa periorbitalis und Pareiitis granulomatosa // Derm. Wschr. 1959. Vol. 139. P. 288.
Schmidt J.B., Gebhart W., Raff M., Spona J. 13-Cis-retinoic acid in rosacea. Clinical and laboratory findings // Acta Derm. Venereol. (Stockh.). 1984. Vol. 64. P. 15–21.
Schmitz S., Zouboulis C.C. Pyoderma faciale (Rosacea fulminans) assoziiert mit Colitis ulcerosa // Z. Hautkr. 1995. Vol. 70. P. 939–940.
Seo J.I., Shin M.K. Lupus miliaris disseminatus faciei versus granulomatous rosacea: a case report // Case Rep. Dermatol. 2021. Vol. 13. N. 2. P. 321–329. DOI: https://doi.org/10.1159/000517209. PMID: 34248540; PMCID: PMC8255731.